Fast Company · Mar 2026
Fast Company named Vivodyne one of the most innovative biotech companies of 2026, citing its automated biological data centers that test 10,000 human tissues at once and its use by top pharmas such as GSK.
Human organ-on-chip platform for drug discovery.
Company research
Public company, workplace, funding, and market signals
Overview
Vivodyne is a San Francisco-based biotechnology company building an automated, AI-enabled platform that generates predictive human data before clinical trials by growing and testing lab-grown human tissues at scale. It sells primarily through custom B2B partnerships with pharmaceutical companies to de-risk and accelerate therapeutics development.
Primary product
An automated human-tissue testing platform that combines lab-grown organ tissues, robotics, and AI to generate predictive preclinical human data.
Founded
2020
Headquarters
San Francisco, California, United States
Team size
30-40 employees
Industry
Biotechnology Research
Sub-industry
Preclinical drug discovery platform using human tissue models, robotics, and AI
Offices
Open Positions
6 jobs at Vivodyne
Lab Operations Specialist
On-siteOperationsPhiladelphia, PA3w ago
On-site